U.S. private equity firm Baird Capital (Click here to listen to co-founding partner of Baird Capital Partners Asia Gu Huaming as a guest on China Money Podcast) has sold its interests in its portfolio company Frontage Laboratories, Inc. to Hangzhou Tigermed Consulting Co., Ltd., a Shenzhen-listed pharmaceutical Contract Research Organization (CRO), according to an announcement […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.